{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:13:55Z","timestamp":1783487635665,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005415","name":"University of Iceland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.canep.2022.102197","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T23:32:36Z","timestamp":1655335956000},"page":"102197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study"],"prefix":"10.1016","volume":"79","author":[{"given":"S.","family":"Snorradottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Asgeirsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"R\u00f6gnvaldsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.canep.2022.102197_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"issue":"11","key":"10.1016\/j.canep.2022.102197_bib2","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3390\/diagnostics11112030","article-title":"Incidence, clinical presentation and trends in indication for diagnostic work-up of small intestinal and pancreatic neuroendocrine tumors","volume":"11","author":"Stensb\u00f8l","year":"2021","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.canep.2022.102197_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00365521.2018.1553061","article-title":"Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study","volume":"54","author":"Gudmundsdottir","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.canep.2022.102197_bib4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canep.2022.102197_bib5","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1245\/s10434-016-5703-4","article-title":"The influence of preoperative symptoms on the death of patients with small intestinal neuroendocrine tumors","volume":"24","author":"Eriksson","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2022.102197_bib6","first-page":"67","article-title":"Colorectal cancer initial diagnosis: screening colonoscopy, diagnostic colonoscopy, or emergent surgery, and tumor stage and size at initial presentation","volume":"15","author":"Moreno","year":"2016","journal-title":"Clin. Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.canep.2022.102197_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.amjsurg.2014.07.014","article-title":"Colon cancer surgery following emergency presentation: effects on admission and stage-adjusted outcomes","volume":"209","author":"Amri","year":"2015","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.canep.2022.102197_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/apt.12519","article-title":"Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study","volume":"39","author":"Hreinsson","year":"2014","journal-title":"Aliment Pharm. Ther."},{"issue":"10","key":"10.1016\/j.canep.2022.102197_bib9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bjc.6603439","article-title":"The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records","volume":"95","author":"Stapley","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.canep.2022.102197_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/0284186X.2012.698751","article-title":"Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness","volume":"51","author":"Sigurdardottir","year":"2012","journal-title":"Acta Oncol."},{"issue":"2","key":"10.1016\/j.canep.2022.102197_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canep.2022.102197_bib12","unstructured":"\u201cPopulation \u2013 key figures 1703\u20132021\u201d. \u3008www.hagstofa.is\u3009. Statistics Iceland. Retrieved 19 June 2021."},{"key":"10.1016\/j.canep.2022.102197_bib13","unstructured":"Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at \u3008www.mortality.org\u3009 (data downloaded on 21 April 2022)."},{"key":"10.1016\/j.canep.2022.102197_bib14","first-page":"84","article-title":"Weighted cox regression using the R Package coxphw","author":"Dunkler","year":"2018","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.canep.2022.102197_bib15","unstructured":"Therneau T. (2021). _A Package for Survival Analysis in R_. R package version 3.2\u201311, <URL: \u3008https:\/\/CRAN.R-project.org\/package=survival\u3009>."},{"key":"10.1016\/j.canep.2022.102197_bib16","first-page":"1","article-title":"Nonparametric relative survival analysis with the R package relative survival","volume":"87","author":"Perm","year":"2018","journal-title":"J. Stat. Softw."},{"issue":"3","key":"10.1016\/j.canep.2022.102197_bib17","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/ERC-13-0125","article-title":"Knowledge NETwork. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature","volume":"21","author":"Fraenkel","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2022.102197_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canep.2022.102197_bib19","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","author":"Norl\u00e9n","year":"2012","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.canep.2022.102197_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s002689900022","article-title":"Clinical manifestations of carcinoid disease","volume":"20","author":"Bax","year":"1996","journal-title":"World J. Surg."},{"issue":"suppl. 6B","key":"10.1016\/j.canep.2022.102197_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(86)90581-4","article-title":"Neuroendocrine tumours: a European view","author":"Buchanan","year":"1986","journal-title":"Am. J. Med"},{"issue":"10","key":"10.1016\/j.canep.2022.102197_bib22","first-page":"828","article-title":"Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study","volume":"43","author":"Le Roux","year":"2011","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"10.1016\/j.canep.2022.102197_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"77 Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:32:07Z","timestamp":1761802327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782122001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":23,"alternative-id":["S1877782122001023"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2022.102197","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2022.102197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102197"}}